{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:21:11Z","timestamp":1793334071690,"version":"4.5.0"},"reference-count":360,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2025KY125"],"award-info":[{"award-number":["2025KY125"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202429"],"award-info":[{"award-number":["82202429"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.redox.2026.104209","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:47:27Z","timestamp":1778762847000},"page":"104209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Crosstalk of thioredoxin system and programmed cell death: from pathophysiology to novel therapy"],"prefix":"10.1016","volume":"94","author":[{"given":"Yunyi","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangqi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoli","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiexin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7519-8531","authenticated-orcid":false,"given":"Jing","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangmin","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.redox.2026.104209_bib1","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00280-019-03912-4","article-title":"The thioredoxin system and cancer therapy: a review","volume":"84","author":"Mohammadi","year":"2019","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"6","key":"10.1016\/j.redox.2026.104209_bib2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.semcancer.2006.10.009","article-title":"The thioredoxin system in cancer","volume":"16","author":"Arn\u00e9r","year":"2006","journal-title":"Semin. Cancer Biol."},{"issue":"5","key":"10.1016\/j.redox.2026.104209_bib3","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/s41590-024-01798-w","article-title":"Thioredoxin is a metabolic rheostat controlling regulatory B cells","volume":"25","author":"Bradford","year":"2024","journal-title":"Nat. Immunol."},{"issue":"7981","key":"10.1016\/j.redox.2026.104209_bib4","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41586-023-06532-4","article-title":"Structural basis for thioredoxin-mediated suppression of NLRP1 inflammasome","volume":"622","author":"Zhang","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.redox.2026.104209_bib5","article-title":"Thioredoxin-1: a promising target for the treatment of allergic diseases","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"issue":"13","key":"10.1016\/j.redox.2026.104209_bib6","doi-asserted-by":"crossref","DOI":"10.1089\/ars.2016.6925","article-title":"Redox signaling mediated by thioredoxin and glutathione systems in the central nervous system","volume":"27","author":"Ren","year":"2017","journal-title":"Antioxidants Redox Signal."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib7","doi-asserted-by":"crossref","DOI":"10.1093\/toxsci\/kfh050","article-title":"Thioredoxin and its role in toxicology","volume":"78","author":"Watson","year":"2003","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.redox.2026.104209_bib15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev.pharmtox.41.1.261","article-title":"Properties and biological activities of thioredoxins","volume":"41","author":"Powis","year":"2001","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"10","key":"10.1016\/j.redox.2026.104209_bib16","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.freeradbiomed.2004.02.072","article-title":"Human mitochondrial thioredoxin reductase reduces cytochrome c and confers resistance to complex III inhibition","volume":"36","author":"Nalvarte","year":"2004","journal-title":"Free Radical Biol. Med."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/152308604771978327","article-title":"The mammalian testis-specific thioredoxin system","volume":"6","author":"Miranda-Vizuete","year":"2004","journal-title":"Antioxidants Redox Signal."},{"issue":"7","key":"10.1016\/j.redox.2026.104209_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10071757","article-title":"The thioredoxin system of mammalian cells and its modulators","volume":"10","author":"Hasan","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.redox.2026.104209_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.abb.2016.09.011","article-title":"Thioredoxin and redox signaling: roles of the thioredoxin system in control of cell fate","volume":"617","author":"Matsuzawa","year":"2016","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.redox.2026.104209_bib9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.freeradbiomed.2019.03.003","article-title":"Evolution of the thioredoxin system as a step enabling adaptation to oxidative stress","volume":"140","author":"Balsera","year":"2019","journal-title":"Free Radical Biol. Med."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.52601\/bpr.2023.230002","article-title":"Antioxidant activity of the thioredoxin system","volume":"9","author":"Liu","year":"2023","journal-title":"Biophys Rep"},{"key":"10.1016\/j.redox.2026.104209_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103032","article-title":"Thioredoxin (Trx): a redox target and modulator of cellular senescence and aging-related diseases","volume":"70","author":"Yang","year":"2024","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.redox.2026.104209_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113682","article-title":"Zn2+-dependent functional switching of ERp18, an ER-resident thioredoxin-like protein","volume":"43","author":"Tsutsumi","year":"2024","journal-title":"Cell Rep."},{"issue":"16","key":"10.1016\/j.redox.2026.104209_bib13","doi-asserted-by":"crossref","first-page":"E3224","DOI":"10.1073\/pnas.1621426114","article-title":"Structural basis of pH-dependent client binding by ERp44, a key regulator of protein secretion at the ER-Golgi interface","volume":"114","author":"Watanabe","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.redox.2026.104209_bib14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1089\/ars.2014.5849","article-title":"The thioredoxin superfamily in oxidative protein folding","volume":"21","author":"Lu","year":"2014","journal-title":"Antioxidants Redox Signal."},{"issue":"2\u20133","key":"10.1016\/j.redox.2026.104209_bib19","first-page":"271","article-title":"Selenium and the thioredoxin and glutaredoxin systems","volume":"10","author":"Bj\u00f6rnstedt","year":"1997","journal-title":"Biomed. Environ. Sci."},{"issue":"Pt 1","key":"10.1016\/j.redox.2026.104209_bib20","first-page":"1","article-title":"Thioredoxin reductase","volume":"346","author":"Mustacich","year":"2000","journal-title":"Biochem. J."},{"issue":"3\u20134","key":"10.1016\/j.redox.2026.104209_bib21","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0891-5849(00)00313-0","article-title":"The role of the redox protein thioredoxin in cell growth and cancer","volume":"29","author":"Powis","year":"2000","journal-title":"Free Radical Biol. Med."},{"issue":"12","key":"10.1016\/j.redox.2026.104209_bib22","doi-asserted-by":"crossref","DOI":"10.1007\/s00109-006-0109-6","article-title":"Thioredoxin in the cardiovascular system","volume":"84","author":"World","year":"2006","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"4","key":"10.1016\/j.redox.2026.104209_bib23","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10637-010-9401-y","article-title":"Thioredoxin reductase inhibitor ethaselen increases the drug sensitivity of the Colon cancer cell line LoVo towards cisplatin via regulation of G1 phase and reversal of G2\/M phase arrest","volume":"29","author":"Fu","year":"2010","journal-title":"Invest. N. Drugs"},{"issue":"5","key":"10.1016\/j.redox.2026.104209_bib24","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41580-023-00689-6","article-title":"A guide to cell death pathways","volume":"25","author":"Yuan","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib25","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s11658-025-00794-8","article-title":"Epitranscriptomic modifications in programmed cell death: mechanistic insights and implications for liver diseases","volume":"30","author":"Chen","year":"2025","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.redox.2026.104209_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103930","article-title":"Ferredoxins: master regulators in mitochondrial redox homeostasis and programmed cell death","volume":"88","author":"Lu","year":"2025","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2026.104209_bib27","article-title":"Elesclomol-copper synergizes with imidazole ketone erastin by promoting cuproptosis and ferroptosis in myelodysplastic syndromes","volume":"175","author":"Gao","year":"2024","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"key":"10.1016\/j.redox.2026.104209_bib28","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2024.06.006","article-title":"GSH exhaustion via inhibition of xCT-GSH-GPX4 pathway synergistically enhanced DSF\/Cu-induced cuproptosis in myelodysplastic syndromes","volume":"222","author":"Li","year":"2024","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.redox.2026.104209_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/j.1749-6632.2000.tb05594.x","article-title":"Programmed cell death (PCD). Apoptosis, autophagic PCD, or others?","volume":"926","author":"Bursch","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.redox.2026.104209_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1309635","article-title":"Programmed cell death in tumor immunity: mechanistic insights and clinical implications","volume":"14","author":"Wang","year":"2024","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.redox.2026.104209_bib31","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1152\/physrev.00036.2024","article-title":"Programmed cell death and tissue regeneration: a link that should be resolved","volume":"105","author":"Kopeina","year":"2025","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s11658-025-00789-5","article-title":"Programmed cell death in triple-negative breast cancer","volume":"30","author":"Liu","year":"2025","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib33","article-title":"Programmed cell death in nasopharyngeal carcinoma: mechanisms and therapeutic targets","volume":"1880","author":"Qian","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.redox.2026.104209_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103788","article-title":"DHODH-mediated mitochondrial redox homeostasis: a novel ferroptosis regulator and promising therapeutic target","volume":"85","author":"Cao","year":"2025","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2026.104209_bib35","article-title":"Ferroptosis mechanisms and its novel potential therapeutic targets for DLBCL","volume":"173","author":"Bian","year":"2024","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"issue":"9","key":"10.1016\/j.redox.2026.104209_bib36","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/s41419-021-04128-2","article-title":"CISD3 inhibition drives cystine-deprivation induced ferroptosis","volume":"12","author":"Li","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.redox.2026.104209_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102122","article-title":"Overcoming the compensatory elevation of NRF2 renders hepatocellular carcinoma cells more vulnerable to disulfiram\/copper-induced ferroptosis","volume":"46","author":"Ren","year":"2021","journal-title":"Redox Biol."},{"issue":"6","key":"10.1016\/j.redox.2026.104209_bib38","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/s41556-025-01673-2","article-title":"Lactate dehydrogenase B facilitates disulfidptosis and exhaustion of tumour-infiltrating CD8+ T cells","volume":"27","author":"Wan","year":"2025","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib39","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12943-025-02445-0","article-title":"Advances in novel cell death mechanisms in breast cancer: intersecting perspectives on ferroptosis, cuproptosis, disulfidptosis, and pyroptosis","volume":"24","author":"Jing","year":"2025","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.redox.2026.104209_bib40","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/s41556-025-01679-w","article-title":"Disulfidptosis meets antitumour immunity","volume":"27","author":"Li","year":"2025","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.redox.2026.104209_bib41","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.bbrc.2006.07.178","article-title":"Nitric oxide induces thioredoxin-1 nuclear translocation: possible association with the p21Ras survival pathway","volume":"348","author":"Arai","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.redox.2026.104209_bib42","first-page":"71","article-title":"Oxidative stress and thioredoxin system","volume":"27","author":"Koh\u00e1ryov\u00e1","year":"2008","journal-title":"Gen. Physiol. Biophys."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib43","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1038\/s41467-024-48076-9","article-title":"The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activity","volume":"15","author":"Prasad","year":"2024","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.redox.2026.104209_bib44","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1093\/emboj\/17.9.2596","article-title":"Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1","volume":"17","author":"Saitoh","year":"1998","journal-title":"EMBO J."},{"issue":"11","key":"10.1016\/j.redox.2026.104209_bib45","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1161\/ATVBAHA.107.149419","article-title":"Nuclear redox-signaling is essential for apoptosis inhibition in endothelial cells--important role for nuclear thioredoxin-1","volume":"27","author":"Schroeder","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"48","key":"10.1016\/j.redox.2026.104209_bib46","doi-asserted-by":"crossref","first-page":"40310","DOI":"10.1074\/jbc.M503644200","article-title":"Extracellular human thioredoxin-1 inhibits lipopolysaccharide-induced interleukin-1beta expression in human monocyte-derived macrophages","volume":"280","author":"Billiet","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.redox.2026.104209_bib47","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1161\/CIRCULATIONAHA.114.012725","article-title":"Thioredoxin-2 inhibits mitochondrial reactive oxygen species generation and apoptosis stress kinase-1 activity to maintain cardiac function","volume":"131","author":"Huang","year":"2015","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.redox.2026.104209_bib48","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/emboj\/21.7.1695","article-title":"Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependent apoptosis","volume":"21","author":"Tanaka","year":"2002","journal-title":"EMBO J."},{"issue":"11","key":"10.1016\/j.redox.2026.104209_bib49","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1089\/ars.2012.4757","article-title":"The thioredoxin system as a therapeutic target in human health and disease","volume":"19","author":"Mahmood","year":"2013","journal-title":"Antioxidants Redox Signal."},{"issue":"6","key":"10.1016\/j.redox.2026.104209_bib50","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1089\/152308603770380106","article-title":"Redox regulation by thioredoxin in cardiovascular diseases","volume":"5","author":"Shioji","year":"2003","journal-title":"Antioxidants Redox Signal."},{"issue":"6","key":"10.1016\/j.redox.2026.104209_bib51","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.semcancer.2006.09.004","article-title":"On the potential of thioredoxin reductase inhibitors for cancer therapy","volume":"16","author":"Urig","year":"2006","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib56","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/152308604771978336","article-title":"Regulation of the mammalian selenoprotein thioredoxin reductase 1 in relation to cellular phenotype, growth, and signaling events","volume":"6","author":"Rundl\u00f6f","year":"2004","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2026.104209_bib57","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bcp.2015.12.004","article-title":"Inhibition of thioredoxin reductase by alantolactone prompts oxidative stress-mediated apoptosis of HeLa cells","volume":"102","author":"Zhang","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.redox.2026.104209_bib52","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.freeradbiomed.2014.10.508","article-title":"Mechanistic characterization of the thioredoxin system in the removal of hydrogen peroxide","volume":"78","author":"Pannala","year":"2014","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.redox.2026.104209_bib53","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.freeradbiomed.2013.07.036","article-title":"The thioredoxin antioxidant system","volume":"66","author":"Lu","year":"2013","journal-title":"Free Radical Biol. Med."},{"issue":"5","key":"10.1016\/j.redox.2026.104209_bib54","article-title":"The importance of Thioredoxin-1 in health and disease","volume":"12","author":"Oberacker","year":"2023","journal-title":"Antioxidants (Basel, Switzerland)"},{"issue":"9","key":"10.1016\/j.redox.2026.104209_bib55","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1089\/ars.2012.4822","article-title":"Interacting with thioredoxin-1--disease or no disease?","volume":"18","author":"Zschauer","year":"2012","journal-title":"Antioxidants Redox Signal."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib58","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bbadis.2016.10.019","article-title":"Securinine disturbs redox homeostasis and elicits oxidative stress-mediated apoptosis via targeting thioredoxin reductase","volume":"1863","author":"Zhang","year":"2016","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"17","key":"10.1016\/j.redox.2026.104209_bib59","doi-asserted-by":"crossref","first-page":"9533","DOI":"10.1073\/pnas.171178698","article-title":"Three-dimensional structure of a mammalian thioredoxin reductase: implications for mechanism and evolution of a selenocysteine-dependent enzyme","volume":"98","author":"Sandalova","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.redox.2026.104209_bib60","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jsb.2016.02.015","article-title":"X-ray structures of thioredoxin and thioredoxin reductase from Entamoeba histolytica and prevailing hypothesis of the mechanism of auranofin action","volume":"194","author":"Parsonage","year":"2016","journal-title":"J. Struct. Biol."},{"issue":"10","key":"10.1016\/j.redox.2026.104209_bib61","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.freeradbiomed.2009.08.015","article-title":"The effects of hexavalent chromium on thioredoxin reductase and peroxiredoxins in human bronchial epithelial cells","volume":"47","author":"Myers","year":"2009","journal-title":"Free Radical Biol. Med."},{"issue":"4","key":"10.1016\/j.redox.2026.104209_bib62","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1042\/BST20150021","article-title":"Interplay between cytosolic disulfide reductase systems and the Nrf2\/Keap1 pathway","volume":"43","author":"Schmidt","year":"2015","journal-title":"Biochem. Soc. Trans."},{"issue":"38","key":"10.1016\/j.redox.2026.104209_bib63","doi-asserted-by":"crossref","first-page":"14105","DOI":"10.1074\/jbc.RA119.009718","article-title":"Functional analyses of ancestral thioredoxins provide insights into their evolutionary history","volume":"294","author":"Napolitano","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.redox.2026.104209_bib64","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1128\/AEM.04221-14","article-title":"Corynebacterium glutamicum methionine sulfoxide reductase A uses both mycoredoxin and thioredoxin for regeneration and oxidative stress resistance","volume":"81","author":"Si","year":"2015","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.redox.2026.104209_bib65","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/1476-4598-13-221","article-title":"A TrxR inhibiting gold(I) NHC complex induces apoptosis through ASK1-p38-MAPK signaling in pancreatic cancer cells","volume":"13","author":"Cheng","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.redox.2026.104209_bib66","article-title":"Modification of Cys residues in human thioredoxin-1 by p-benzoquinone causes inhibition of its catalytic activity and activation of the ASK1\/p38-MAPK signalling pathway","volume":"29","author":"Shu","year":"2019","journal-title":"Redox Biol."},{"issue":"11","key":"10.1016\/j.redox.2026.104209_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25115675","article-title":"Antioxidant enzymes and their potential use in breast cancer treatment","volume":"25","author":"Vilchis-Landeros","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2026.104209_bib68","article-title":"Chemistry, structure, and biological roles of Au-NHC complexes as TrxR inhibitors","volume":"95","author":"Karaaslan","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.redox.2026.104209_bib69","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.toxicon.2017.10.028","article-title":"Hsp90 and thioredoxin-thioredoxin reductase enable the catalytic activity of clostridial neurotoxins inside nerve terminals","volume":"147","author":"Pirazzini","year":"2017","journal-title":"Toxicon"},{"key":"10.1016\/j.redox.2026.104209_bib70","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.freeradbiomed.2020.02.027","article-title":"Lipid peroxidation and ferroptosis: the role of GSH and GPx4","volume":"152","author":"Ursini","year":"2020","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.redox.2026.104209_bib71","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.plaphy.2013.05.032","article-title":"Glutathione and glutathione reductase: a boon in disguise for plant abiotic stress defense operations","volume":"70","author":"Gill","year":"2013","journal-title":"Plant Physiol. Biochem."},{"issue":"13","key":"10.1016\/j.redox.2026.104209_bib72","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1089\/ars.2012.5007","article-title":"Glutaredoxins in thiol\/disulfide exchange","volume":"18","author":"Lillig","year":"2012","journal-title":"Antioxidants Redox Signal."},{"issue":"10","key":"10.1016\/j.redox.2026.104209_bib73","article-title":"Glutathione and glutaredoxin in redox regulation and cell signaling of the lens","volume":"11","author":"Lou","year":"2022","journal-title":"Antioxidants (Basel, Switzerland)"},{"issue":"8","key":"10.1016\/j.redox.2026.104209_bib74","article-title":"Glutathione and glutaredoxin-key players in cellular redox homeostasis and signaling","volume":"12","author":"Chai","year":"2023","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"10.1016\/j.redox.2026.104209_bib75","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.freeradbiomed.2015.02.017","article-title":"Understanding mammalian glutathione peroxidase 7 in the light of its homologs","volume":"83","author":"Maiorino","year":"2015","journal-title":"Free Radical Biol. Med."},{"issue":"22","key":"10.1016\/j.redox.2026.104209_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216388","article-title":"Overexpression of grapevine VyTRXy improves drought tolerance by maintaining photosynthesis and enhancing the antioxidant and osmolyte capacity of plants","volume":"24","author":"Xiang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2026.104209_bib77","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.plaphy.2022.11.036","article-title":"Trx CDSP32-overexpressing tobacco plants improves cadmium tolerance by modulating antioxidant mechanism","volume":"194","author":"Zhang","year":"2022","journal-title":"Plant Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib78","article-title":"Investigating the thioredoxin and glutathione systems' response in lymphoma cells after treatment with [Au(d2pype)2]CL","volume":"10","author":"Wang","year":"2021","journal-title":"Antioxidants (Basel, Switzerland)"},{"issue":"7","key":"10.1016\/j.redox.2026.104209_bib79","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41419-022-05121-z","article-title":"Hypoxia aggravates ferroptosis in RPE cells by promoting the Fenton reaction","volume":"13","author":"Henning","year":"2022","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.redox.2026.104209_bib80","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","article-title":"Reactive oxygen species (ROS) as pleiotropic physiological signalling agents","volume":"21","author":"Sies","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib81","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/s42003-022-04017-0","article-title":"Structural analysis of the overoxidized Cu\/Zn-superoxide dismutase in ROS-induced ALS filament formation","volume":"5","author":"Baek","year":"2022","journal-title":"Commun. Biol."},{"issue":"19","key":"10.1016\/j.redox.2026.104209_bib82","doi-asserted-by":"crossref","first-page":"10829","DOI":"10.1021\/acs.chemrev.9b00371","article-title":"Catalysis of peroxide reduction by fast reacting protein thiols","volume":"119","author":"Zeida","year":"2019","journal-title":"Chem. Rev."},{"issue":"12","key":"10.1016\/j.redox.2026.104209_bib83","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.freeradbiomed.2005.02.026","article-title":"Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling","volume":"38","author":"Rhee","year":"2005","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.redox.2026.104209_bib84","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/B978-0-12-405882-8.00003-9","article-title":"Peroxiredoxins as preferential targets in H2O2-induced signaling","volume":"527","author":"Randall","year":"2013","journal-title":"Methods Enzymol."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib85","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1152\/physrev.00018.2001","article-title":"Free radicals in the physiological control of cell function","volume":"82","author":"Dr\u00f6ge","year":"2002","journal-title":"Physiol. Rev."},{"issue":"53","key":"10.1016\/j.redox.2026.104209_bib86","doi-asserted-by":"crossref","first-page":"pe1","DOI":"10.1126\/stke.2000.53.pe1","article-title":"Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation","volume":"2000","author":"Rhee","year":"2000","journal-title":"Sci. STKE"},{"issue":"3","key":"10.1016\/j.redox.2026.104209_bib87","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/ars.2012.4716","article-title":"Thioredoxin and thioredoxin reductase in relation to reversible S-nitrosylation","volume":"18","author":"Sengupta","year":"2012","journal-title":"Antioxidants Redox Signal."},{"issue":"10","key":"10.1016\/j.redox.2026.104209_bib88","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1093\/jxb\/erv146","article-title":"The thioredoxin\/peroxiredoxin\/sulfiredoxin system: current overview on its redox function in plants and regulation by reactive oxygen and nitrogen species","volume":"66","author":"Sevilla","year":"2015","journal-title":"J. Exp. Bot."},{"issue":"24","key":"10.1016\/j.redox.2026.104209_bib89","doi-asserted-by":"crossref","first-page":"13963","DOI":"10.1016\/S0021-9258(18)71625-6","article-title":"Thioredoxin and glutaredoxin systems","volume":"264","author":"Holmgren","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2026.104209_bib90","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.abb.2018.09.002","article-title":"Role of the glutaredoxin domain and FAD in the stabilization of thioredoxin glutathione reductase","volume":"656","author":"Kalita","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"issue":"3","key":"10.1016\/j.redox.2026.104209_bib91","doi-asserted-by":"crossref","first-page":"H1227","DOI":"10.1152\/ajpheart.01162.2006","article-title":"Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: implications for diseases in the cardiovascular system","volume":"292","author":"Berndt","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/j.redox.2026.104209_bib92","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-00478-8","article-title":"Redox regulation of immunometabolism","volume":"21","author":"Muri","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib93","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41420-025-02491-z","article-title":"Targeting epigenetic and post-translational modifications of NRF2: key regulatory factors in disease treatment","volume":"11","author":"Yang","year":"2025","journal-title":"Cell Death Discov."},{"issue":"10","key":"10.1016\/j.redox.2026.104209_bib94","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1089\/ars.2015.6378","article-title":"TrxR1 as a potent regulator of the Nrf2-Keap1 response system","volume":"23","author":"Cebula","year":"2015","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2026.104209_bib95","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3389\/fnins.2020.00267","article-title":"Nrf2 and ferroptosis: a new research direction for neurodegenerative diseases","volume":"14","author":"Song","year":"2020","journal-title":"Front. Neurosci."},{"issue":"12","key":"10.1016\/j.redox.2026.104209_bib96","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1089\/ars.2016.6795","article-title":"Nuclear factor (Erythroid-Derived 2)-Like 2 and Thioredoxin-1 in atherosclerosis and ischemia\/reperfusion injury in the heart","volume":"26","author":"Jakobs","year":"2017","journal-title":"Antioxidants Redox Signal."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib97","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/ars.2007.9.25","article-title":"Thioredoxin and related molecules--from biology to health and disease","volume":"9","author":"Lillig","year":"2007","journal-title":"Antioxidants Redox Signal."},{"issue":"19","key":"10.1016\/j.redox.2026.104209_bib98","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1021\/bi00612a031","article-title":"Tissue distribution and subcellular localization of bovine thioredoxin determined by radioimmunoassay","volume":"17","author":"Holmgren","year":"1978","journal-title":"Biochemistry"},{"issue":"8","key":"10.1016\/j.redox.2026.104209_bib99","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1073\/pnas.94.8.3633","article-title":"AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1","volume":"94","author":"Hirota","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib100","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.bbagen.2013.09.013","article-title":"Regulation of the human thioredoxin gene promoter and its key substrates: a study of functional and putative regulatory elements","volume":"1840","author":"Hawkes","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.redox.2026.104209_bib101","article-title":"Reactive oxygen species signaling and oxidative stress: transcriptional regulation and evolution","volume":"13","author":"Hong","year":"2024","journal-title":"Antioxidants (Basel, Switzerland)"},{"issue":"2","key":"10.1016\/j.redox.2026.104209_bib102","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3390\/cancers2020209","article-title":"Thioredoxin and cancer: a role for thioredoxin in all states of tumor oxygenation","volume":"2","author":"Karlenius","year":"2010","journal-title":"Cancers"},{"key":"10.1016\/j.redox.2026.104209_bib103","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.18.1.621","article-title":"Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity","volume":"18","author":"Karin","year":"2000","journal-title":"Annu. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.redox.2026.104209_bib104","doi-asserted-by":"crossref","first-page":"RE1","DOI":"10.1126\/stke.1999.5.re1","article-title":"The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus","volume":"1999","author":"Rothwarf","year":"1999","journal-title":"Sci. STKE"},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib105","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tibs.2004.11.009","article-title":"Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation","volume":"30","author":"Viatour","year":"2005","journal-title":"Trends Biochem. Sci."},{"issue":"8","key":"10.1016\/j.redox.2026.104209_bib106","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1002\/j.1460-2075.1991.tb07761.x","article-title":"Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1","volume":"10","author":"Schreck","year":"1991","journal-title":"EMBO J."},{"key":"10.1016\/j.redox.2026.104209_bib107","article-title":"Nuclear factor kappa B expression in non-small cell lung cancer","volume":"167","author":"Zhang","year":"2023","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"issue":"3","key":"10.1016\/j.redox.2026.104209_bib108","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1042\/BJ20090107","article-title":"Interaction of mitochondrial thioredoxin with glucocorticoid receptor and NF-kappaB modulates glucocorticoid receptor and NF-kappaB signalling in HEK-293 cells","volume":"422","author":"Psarra","year":"2009","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.redox.2026.104209_bib109","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11325-022-02640-z","article-title":"Prospect of thioredoxin as a possibly effective tool to combat OSAHS","volume":"27","author":"Pan","year":"2022","journal-title":"Sleep Breath."},{"issue":"9\u201310","key":"10.1016\/j.redox.2026.104209_bib110","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1089\/ars.2006.8.1729","article-title":"The role of apoptosis signal-regulating kinase 1 in cardiomyocyte apoptosis","volume":"8","author":"Nishida","year":"2006","journal-title":"Antioxidants Redox Signal."},{"issue":"4\u20136","key":"10.1016\/j.redox.2026.104209_bib111","first-page":"403","article-title":"Thioredoxin signaling pathways in cancer","volume":"38","author":"Zhang","year":"2022","journal-title":"Antioxidants Redox Signal."},{"issue":"4","key":"10.1016\/j.redox.2026.104209_bib112","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4618","article-title":"Functional analysis of protein post-translational modifications using genetic codon expansion","volume":"32","author":"Peng","year":"2023","journal-title":"Protein Sci."},{"issue":"9","key":"10.1016\/j.redox.2026.104209_bib113","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1089\/ars.2010.3831","article-title":"Thioredoxin 1-mediated post-translational modifications: reduction, transnitrosylation, denitrosylation, and related proteomics methodologies","volume":"15","author":"Wu","year":"2011","journal-title":"Antioxidants Redox Signal."},{"issue":"2","key":"10.1016\/j.redox.2026.104209_bib114","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bbrc.2015.10.003","article-title":"Crystal structure of fully oxidized human thioredoxin","volume":"467","author":"Hwang","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"32","key":"10.1016\/j.redox.2026.104209_bib115","doi-asserted-by":"crossref","first-page":"21890","DOI":"10.1074\/jbc.M801047200","article-title":"Regulation of the catalytic activity and structure of human thioredoxin 1 via oxidation and S-nitrosylation of cysteine residues","volume":"283","author":"Hashemy","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.redox.2026.104209_bib116","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.freeradbiomed.2012.09.019","article-title":"In vivo redox state of human thioredoxin and redox shift by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA)","volume":"53","author":"Ungerstedt","year":"2012","journal-title":"Free Radical Biol. Med."},{"issue":"29","key":"10.1016\/j.redox.2026.104209_bib117","doi-asserted-by":"crossref","first-page":"15020","DOI":"10.1074\/jbc.M116.729426","article-title":"Sulfur denitrosylation by an engineered trx-like DsbG enzyme identifies nucleophilic cysteine hydrogen bonds as key functional determinant","volume":"291","author":"Lafaye","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"7\u20138","key":"10.1016\/j.redox.2026.104209_bib118","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.lfs.2010.06.018","article-title":"Thioredoxin-1 phosphorylated at T100 is needed for its anti-apoptotic activity in HepG2 cancer cells","volume":"87","author":"Chen","year":"2010","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.redox.2026.104209_bib119","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.2353\/ajpath.2007.070218","article-title":"Reactive aldehyde modification of thioredoxin-1 activates early steps of inflammation and cell adhesion","volume":"171","author":"Go","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"13","key":"10.1016\/j.redox.2026.104209_bib120","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1161\/CIRCULATIONAHA.106.625061","article-title":"Nitrative inactivation of thioredoxin-1 and its role in postischemic myocardial apoptosis","volume":"114","author":"Tao","year":"2006","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.redox.2026.104209_bib121","doi-asserted-by":"crossref","DOI":"10.1172\/JCI190215","article-title":"Coenzyme A protects against ferroptosis via CoAlation of mitochondrial thioredoxin reductase","volume":"135","author":"Lin","year":"2025","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.redox.2026.104209_bib122","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0092-8674(04)00046-7","article-title":"Cell death: critical control points","volume":"116","author":"Danial","year":"2004","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.redox.2026.104209_bib123","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/bjc.1972.33","article-title":"Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics","volume":"26","author":"Kerr","year":"1972","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib124","doi-asserted-by":"crossref","DOI":"10.1155\/S0962935195000020","article-title":"Apoptosis and inflammation","volume":"4","author":"Haanen","year":"1995","journal-title":"Mediat. Inflamm."},{"issue":"2","key":"10.1016\/j.redox.2026.104209_bib125","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1152\/physrev.00011.2017","article-title":"Neuronal cell death","volume":"98","author":"Fricker","year":"2018","journal-title":"Physiol. Rev."},{"issue":"11\u201312","key":"10.1016\/j.redox.2026.104209_bib126","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1007\/s10495-023-01882-w","article-title":"Role of APR3 in cancer: apoptosis, autophagy, oxidative stress, and cancer therapy","volume":"28","author":"Zhang","year":"2023","journal-title":"Apoptosis"},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib127","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-pathmechdis-051222-115023","article-title":"Apoptosis in cancer biology and therapy","volume":"20","author":"Moyer","year":"2025","journal-title":"Annu. Rev. Pathol."},{"issue":"4","key":"10.1016\/j.redox.2026.104209_bib128","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001846","article-title":"Cell death by SecTRAPs: thioredoxin reductase as a prooxidant killer of cells","volume":"3","author":"Anest\u00e5l","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.redox.2026.104209_bib129","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.freeradbiomed.2019.03.014","article-title":"Promotion of HeLa cells apoptosis by cynaropicrin involving inhibition of thioredoxin reductase and induction of oxidative stress","volume":"135","author":"Liu","year":"2019","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.redox.2026.104209_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101153","article-title":"Peperomin E and its orally bioavailable analog induce oxidative stress-mediated apoptosis of acute myeloid leukemia progenitor cells by targeting thioredoxin reductase","volume":"24","author":"Wang","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2026.104209_bib131","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.freeradbiomed.2021.12.314","article-title":"Thioredoxin reductase 1 inhibitor shikonin promotes cell necroptosis via SecTRAPs generation and oxygen-coupled redox cycling","volume":"180","author":"Zhang","year":"2021","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.redox.2026.104209_bib132","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.freeradbiomed.2017.12.029","article-title":"The A to Z of modulated cell patterning by mammalian thioredoxin reductases","volume":"115","author":"Dagnell","year":"2017","journal-title":"Free Radical Biol. Med."},{"issue":"23","key":"10.1016\/j.redox.2026.104209_bib133","doi-asserted-by":"crossref","first-page":"11408","DOI":"10.1073\/pnas.1903244116","article-title":"TrxR1, Gsr, and oxidative stress determine hepatocellular carcinoma malignancy","volume":"116","author":"McLoughlin","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.redox.2026.104209_bib134","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1093\/carcin\/bgl111","article-title":"Thioredoxin reductase is required for the inactivation of tumor suppressor p53 and for apoptosis induced by endogenous electrophiles","volume":"27","author":"Cassidy","year":"2006","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.redox.2026.104209_bib135","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1074\/jbc.M211134200","article-title":"Electrophilic prostaglandins and lipid aldehydes repress redox-sensitive transcription factors p53 and hypoxia-inducible factor by impairing the selenoprotein thioredoxin reductase","volume":"278","author":"Moos","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2026.104209_bib136","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejphar.2019.04.051","article-title":"Daucosterol disturbs redox homeostasis and elicits oxidative-stress mediated apoptosis in A549 cells via targeting thioredoxin reductase by a p53 dependent mechanism","volume":"855","author":"Rajavel","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.redox.2026.104209_bib137","article-title":"Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer","volume":"42","author":"Freire","year":"2021","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.redox.2026.104209_bib138","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/embo-reports\/kve046","article-title":"ASK1 is required for sustained activations of JNK\/p38 MAP kinases and apoptosis","volume":"2","author":"Tobiume","year":"2001","journal-title":"EMBO Rep."},{"issue":"11","key":"10.1016\/j.redox.2026.104209_bib139","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.bbagen.2007.12.011","article-title":"Redox control of cell fate by MAP kinase: physiological roles of ASK1-MAP kinase pathway in stress signaling","volume":"1780","author":"Matsuzawa","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.redox.2026.104209_bib140","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1021\/acs.biochem.7b01083","article-title":"Redox-inactive peptide disrupting Trx1-Ask1 interaction for selective activation of stress signaling","volume":"57","author":"Kekulandara","year":"2018","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib141","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.freeradbiomed.2011.04.030","article-title":"Depletion of cytosolic or mitochondrial thioredoxin increases CYP2E1-induced oxidative stress via an ASK-1-JNK1 pathway in HepG2 cells","volume":"51","author":"Yang","year":"2011","journal-title":"Free Radical Biol. Med."},{"issue":"11","key":"10.1016\/j.redox.2026.104209_bib142","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/01.RES.0000130525.37646.a7","article-title":"Thioredoxin-2 inhibits mitochondria-located ASK1-mediated apoptosis in a JNK-independent manner","volume":"94","author":"Zhang","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.redox.2026.104209_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2025.115326","article-title":"Overexpression of thioredoxin 1 contributes to neuroprotection through ATM activation and pentose phosphate pathway modulation after traumatic brain injury","volume":"392","author":"Meng","year":"2025","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.redox.2026.104209_bib144","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2024.2398710","article-title":"Chrysophanol-mediated trx-1 activation attenuates renal fibrosis through inhibition of the JNK\/Cx43 signaling pathway","volume":"46","author":"Bao","year":"2024","journal-title":"Ren. Fail."},{"issue":"50","key":"10.1016\/j.redox.2026.104209_bib145","doi-asserted-by":"crossref","first-page":"35809","DOI":"10.1074\/jbc.274.50.35809","article-title":"Thioredoxin-dependent redox regulation of p53-mediated p21 activation","volume":"274","author":"Ueno","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib146","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s13287-017-0711-2","article-title":"Thioredoxin mitigates radiation-induced hematopoietic stem cell injury in mice","volume":"8","author":"Sundaramoorthy","year":"2017","journal-title":"Stem Cell Res. Ther."},{"issue":"3","key":"10.1016\/j.redox.2026.104209_bib147","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41556-023-01091-2","article-title":"Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis","volume":"25","author":"Liu","year":"2023","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.redox.2026.104209_bib148","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.tcb.2023.07.009","article-title":"Disulfidptosis: disulfide stress-induced cell death","volume":"34","author":"Liu","year":"2023","journal-title":"Trends Cell Biol."},{"issue":"6","key":"10.1016\/j.redox.2026.104209_bib149","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.freeradbiomed.2007.05.032","article-title":"Thioredoxin and thioredoxin-binding protein-2 in cancer and metabolic syndrome","volume":"43","author":"Kaimul","year":"2007","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.redox.2026.104209_bib150","article-title":"The molecular mechanisms of disulfidptosis and its role in diabetes mellitus and its complications","volume":"191","author":"Zhang","year":"2025","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"key":"10.1016\/j.redox.2026.104209_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102711","article-title":"NFATc1-mediated expression of SLC7A11 drives sensitivity to TXNRD1 inhibitors in osteoclast precursors","volume":"63","author":"Zhong","year":"2023","journal-title":"Redox Biol."},{"issue":"4","key":"10.1016\/j.redox.2026.104209_bib152","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41418-024-01440-0","article-title":"Inhibition of thioredoxin reductase 1 sensitizes glucose-starved glioblastoma cells to disulfidptosis","volume":"32","author":"Tang","year":"2024","journal-title":"Cell Death Differ."},{"issue":"5","key":"10.1016\/j.redox.2026.104209_bib153","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.redox.2026.104209_bib154","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.molcel.2022.03.022","article-title":"Ferroptosis at the intersection of lipid metabolism and cellular signaling","volume":"82","author":"Liang","year":"2022","journal-title":"Mol. Cell"},{"issue":"7","key":"10.1016\/j.redox.2026.104209_bib155","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41419-021-03996-y","article-title":"DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism","volume":"12","author":"Du","year":"2021","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib156","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1186\/s12935-021-02420-x","article-title":"FTH promotes the proliferation and renders the HCC cells specifically resist to ferroptosis by maintaining iron homeostasis","volume":"21","author":"Hu","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib157","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12964-024-01520-1","article-title":"Regulation of NCOA4-mediated iron recycling ameliorates paraquat-induced lung injury by inhibiting ferroptosis","volume":"22","author":"Du","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.redox.2026.104209_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101483","article-title":"Identification of frataxin as a regulator of ferroptosis","volume":"32","author":"Du","year":"2020","journal-title":"Redox Biol."},{"issue":"14","key":"10.1016\/j.redox.2026.104209_bib159","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.redox.2026.104209_bib160","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s00204-023-03476-6","article-title":"ROS-Induced lipid peroxidation modulates cell death outcome: mechanisms behind apoptosis, autophagy, and ferroptosis","volume":"97","author":"Wang","year":"2023","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.redox.2026.104209_bib161","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1226044","article-title":"ROS induced lipid peroxidation and their role in ferroptosis","volume":"11","author":"Endale","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.redox.2026.104209_bib162","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","article-title":"Ferroptosis: death by lipid peroxidation","volume":"26","author":"Yang","year":"2015","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.redox.2026.104209_bib163","article-title":"Inhibiting the compensatory elevation of xCT collaborates with disulfiram\/copper-induced GSH consumption for cascade ferroptosis and cuproptosis","volume":"69","author":"Zhang","year":"2023","journal-title":"Redox Biol."},{"issue":"4","key":"10.1016\/j.redox.2026.104209_bib164","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.redox.2026.104209_bib165","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2020","journal-title":"Cell Res."},{"issue":"6","key":"10.1016\/j.redox.2026.104209_bib166","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1080\/15548627.2024.2319901","article-title":"International consensus guidelines for the definition, detection, and interpretation of autophagy-dependent ferroptosis","volume":"20","author":"Chen","year":"2024","journal-title":"Autophagy"},{"key":"10.1016\/j.redox.2026.104209_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108373","article-title":"Molecular mechanisms of ferroptosis and their involvement in brain diseases","volume":"244","author":"Costa","year":"2023","journal-title":"Pharmacol. Therapeut."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib168","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s11658-022-00383-z","article-title":"Inhibition of CISD2 promotes ferroptosis through ferritinophagy-mediated ferritin turnover and regulation of p62-Keap1-NRF2 pathway","volume":"27","author":"Li","year":"2022","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"9","key":"10.1016\/j.redox.2026.104209_bib169","article-title":"Exploring the thioredoxin system as a therapeutic target in cancer: mechanisms and implications","volume":"13","author":"Seitz","year":"2024","journal-title":"Antioxidants (Basel, Switzerland)"},{"issue":"7","key":"10.1016\/j.redox.2026.104209_bib170","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1007\/s12035-021-02320-1","article-title":"Thioredoxin-1 rescues MPP+\/MPTP-Induced ferroptosis by increasing glutathione peroxidase 4","volume":"58","author":"Bai","year":"2021","journal-title":"Mol. Neurobiol."},{"issue":"8","key":"10.1016\/j.redox.2026.104209_bib171","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1089\/ars.2014.6187","article-title":"Effective killing of cancer cells through ROS-mediated mechanisms by AMRI-59 targeting peroxiredoxin I","volume":"24","author":"Yang","year":"2015","journal-title":"Antioxidants Redox Signal."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib172","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41392-020-00253-0","article-title":"Auranofin mitigates systemic iron overload and induces ferroptosis via distinct mechanisms","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib173","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s42003-024-06452-7","article-title":"Retinoic acid receptor alpha inhibits ferroptosis by promoting thioredoxin and protein phosphatase 1F in lung adenocarcinoma","volume":"7","author":"Bian","year":"2024","journal-title":"Commun. Biol."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib174","doi-asserted-by":"crossref","first-page":"8181","DOI":"10.1038\/s41467-025-63687-6","article-title":"Targeting ALDH16A1 mediated thioredoxin lysosomal degradation to enhance ferroptosis susceptibility in SMARCA4-deficient NSCLC","volume":"16","author":"Bi","year":"2025","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.redox.2026.104209_bib175","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/j.2040-4603.2015.tb00622.x","article-title":"Thioredoxin superfamily and its effects on cardiac physiology and pathology","volume":"5","author":"Yoshioka","year":"2015","journal-title":"Compr. Physiol."},{"issue":"4","key":"10.1016\/j.redox.2026.104209_bib176","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","article-title":"Autophagy: renovation of cells and tissues","volume":"147","author":"Mizushima","year":"2011","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.redox.2026.104209_bib177","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41419-023-06154-8","article-title":"Autophagy: regulator of cell death","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.redox.2026.104209_bib178","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.734818","article-title":"TEOA promotes autophagic cell death via ROS-mediated inhibition of mTOR\/p70S6k signaling pathway in pancreatic cancer cells","volume":"9","author":"Yang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib179","doi-asserted-by":"crossref","DOI":"10.1002\/path.2697","article-title":"Autophagy: cellular and molecular mechanisms","volume":"221","author":"Glick","year":"2010","journal-title":"J. Pathol."},{"issue":"16","key":"10.1016\/j.redox.2026.104209_bib180","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMra2022774","article-title":"Autophagy in human diseases","volume":"383","author":"Mizushima","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2026.104209_bib181","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109788","article-title":"Thioredoxin upregulation delays diabetes-induced photoreceptor cell degeneration via AMPK-Mediated autophagy and exosome secretion","volume":"185","author":"Ren","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.redox.2026.104209_bib182","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109025","article-title":"Upregulation of thioredoxin contributes to inhibiting diabetic hearing impairment","volume":"179","author":"Ren","year":"2021","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib183","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41420-024-01848-0","article-title":"Thioredoxin-1 decreases alpha-synuclein induced by MPTP through promoting autophagy-lysosome pathway","volume":"10","author":"Gu","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.redox.2026.104209_bib184","article-title":"Notoginsenoside R1 protects against the acrylamide-induced neurotoxicity via upregulating Trx-1-Mediated ITGAV expression: involvement of autophagy","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.redox.2026.104209_bib185","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s11427-023-2563-6","article-title":"Isowalsuranolide targets TrxR1\/2 and triggers lysosomal biogenesis and autophagy via the p53-TFEB\/TFE3 axis","volume":"68","author":"Yang","year":"2025","journal-title":"Sci. China Life Sci."},{"issue":"2","key":"10.1016\/j.redox.2026.104209_bib186","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nchembio711","article-title":"Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury","volume":"1","author":"Degterev","year":"2005","journal-title":"Nat. Chem. Biol."},{"issue":"7784","key":"10.1016\/j.redox.2026.104209_bib187","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41586-019-1770-6","article-title":"Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis","volume":"575","author":"Fritsch","year":"2019","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.redox.2026.104209_bib188","doi-asserted-by":"crossref","DOI":"10.1016\/j.mocell.2025.100199","article-title":"RIPK3 in necroptosis and cancer","volume":"48","author":"Morgan","year":"2025","journal-title":"Mol. Cells"},{"issue":"10","key":"10.1016\/j.redox.2026.104209_bib189","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1038\/s12276-022-00868-z","article-title":"Roles of RIPK3 in necroptosis, cell signaling, and disease","volume":"54","author":"Morgan","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.redox.2026.104209_bib190","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.663481","article-title":"Thioredoxin reductase is a valid target for antimicrobial therapeutic development against gram-positive bacteria","volume":"12","author":"Felix","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.redox.2026.104209_bib191","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.phrs.2016.11.011","article-title":"Shikonin inhibits gefitinib-resistant non-small cell lung cancer by inhibiting TrxR and activating the EGFR proteasomal degradation pathway","volume":"115","author":"Li","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"42","key":"10.1016\/j.redox.2026.104209_bib192","doi-asserted-by":"crossref","first-page":"17514","DOI":"10.1074\/jbc.M117.799353","article-title":"Thioredoxin-1 actively maintains the pseudokinase MLKL in a reduced state to suppress disulfide bond-dependent MLKL polymer formation and necroptosis","volume":"292","author":"Reynoso","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib193","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-021-00507-5","article-title":"Pyroptosis: mechanisms and diseases","volume":"6","author":"Yu","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"6","key":"10.1016\/j.redox.2026.104209_bib194","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.redox.2026.104209_bib195","doi-asserted-by":"crossref","first-page":"9723","DOI":"10.1007\/s12035-024-04341-y","article-title":"Thioredoxin-1 protects neurons through inhibiting NLRP1-Mediated neuronal pyroptosis in models of Alzheimer's disease","volume":"61","author":"Jia","year":"2024","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib196","article-title":"Thioredoxin-1 inhibits NLRP3-mediated pyroptosis by regulating TXNIP in models of Alzheimer's disease","volume":"15","author":"Jia","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib197","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40364-024-00593-x","article-title":"Disulfidptosis decoded: a journey through cell death mysteries, regulatory networks, disease paradigms and future directions","volume":"12","author":"Chen","year":"2024","journal-title":"Biomark. Res."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib198","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41420-025-02328-9","article-title":"Insights on the crosstalk among different cell death mechanisms","volume":"11","author":"Eskander","year":"2025","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib199","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/dbio.1996.0208","article-title":"Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene","volume":"178","author":"Matsui","year":"1996","journal-title":"Dev. Biol."},{"key":"10.1016\/j.redox.2026.104209_bib200","series-title":"Selenium: Its Molecular Biology and Role in Human Health","first-page":"195","article-title":"Mitochondrial and cytosolic thioredoxin reductase knockout mice","author":"Conrad","year":"2006"},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib201","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.cbi.2011.04.009","article-title":"Radiosensitization by celastrol is mediated by modification of antioxidant thiol molecules","volume":"193","author":"Seo","year":"2011","journal-title":"Chem. Biol. Interact."},{"issue":"9","key":"10.1016\/j.redox.2026.104209_bib202","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.tips.2017.06.001","article-title":"Targeting the thioredoxin system for cancer therapy","volume":"38","author":"Zhang","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.redox.2026.104209_bib203","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/17460441.2022.2045270","article-title":"Novel strategies for targeting the thioredoxin system for cancer therapy","volume":"17","author":"Xu","year":"2022","journal-title":"Expert Opin. Drug Discov."},{"issue":"16","key":"10.1016\/j.redox.2026.104209_bib204","doi-asserted-by":"crossref","first-page":"7309","DOI":"10.1021\/acs.jmedchem.8b01595","article-title":"Targeting the thioredoxin system as a strategy for cancer therapy","volume":"62","author":"Bian","year":"2019","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.redox.2026.104209_bib205","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1006\/bbrc.2000.3689","article-title":"Thioredoxin, a singlet oxygen quencher and hydroxyl radical scavenger: redox independent functions","volume":"277","author":"Das","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.redox.2026.104209_bib206","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1111\/cas.15068","article-title":"Reactive oxygen species in cancer: current findings and future directions","volume":"112","author":"Nakamura","year":"2021","journal-title":"Cancer Sci."},{"issue":"6","key":"10.1016\/j.redox.2026.104209_bib207","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1080\/10715760000301361","article-title":"Redox regulation by thioredoxin superfamily; protection against oxidative stress and aging","volume":"33","author":"Tanaka","year":"2000","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.redox.2026.104209_bib208","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1749-6632.2002.tb02916.x","article-title":"Thioredoxin superfamily and thioredoxin-inducing agents","volume":"957","author":"Hirota","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib209","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/14756366.2020.1867121","article-title":"Thioredoxin-dependent system. Application of inhibitors","volume":"36","author":"Jastrz\u0105b","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.redox.2026.104209_bib210","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.freeradbiomed.2017.07.029","article-title":"Redox regulation of the tumor suppressor PTEN by the thioredoxin system and cumene hydroperoxide","volume":"112","author":"Han","year":"2017","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.redox.2026.104209_bib211","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev-genet-102108-134201","article-title":"Thioredoxins and glutaredoxins: unifying elements in redox biology","volume":"43","author":"Meyer","year":"2009","journal-title":"Annu. Rev. Genet."},{"issue":"13\u201315","key":"10.1016\/j.redox.2026.104209_bib212","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1089\/ars.2021.0199","article-title":"Thiol-based antioxidants and the epithelial\/mesenchymal transition in cancer","volume":"36","author":"Ogata","year":"2022","journal-title":"Antioxidants Redox Signal."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib213","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00280-023-04548-1","article-title":"A biscarbene gold(I)-NHC-complex overcomes cisplatin-resistance in A2780 and W1 ovarian cancer cells highlighting pERK as regulator of apoptosis","volume":"92","author":"K\u00f6nig","year":"2023","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"2","key":"10.1016\/j.redox.2026.104209_bib214","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s12012-020-09605-2","article-title":"Thioredoxin decreases anthracycline cardiotoxicity, but sensitizes cancer cell apoptosis","volume":"21","author":"Das","year":"2020","journal-title":"Cardiovasc. Toxicol."},{"issue":"5","key":"10.1016\/j.redox.2026.104209_bib215","doi-asserted-by":"crossref","first-page":"6737","DOI":"10.1007\/s13277-015-4424-9","article-title":"Combating trastuzumab resistance by targeting thioredoxin-1\/PTEN interaction","volume":"37","author":"Sadeghirizi","year":"2015","journal-title":"Tumour Biol"},{"issue":"2","key":"10.1016\/j.redox.2026.104209_bib216","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s13402-023-00887-6","article-title":"Inhibition of thioredoxin-1 enhances the toxicity of glycolysis inhibitor 2-deoxyglucose by downregulating SLC1A5 expression in colorectal cancer cells","volume":"47","author":"Tang","year":"2023","journal-title":"Cell Oncol (Dordr)"},{"issue":"3","key":"10.1016\/j.redox.2026.104209_bib217","doi-asserted-by":"crossref","first-page":"314","DOI":"10.18632\/oncotarget.463","article-title":"Over-expression of Thioredoxin-1 mediates growth, survival, and chemoresistance and is a druggable target in diffuse large B-cell lymphoma","volume":"3","author":"Li","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.redox.2026.104209_bib218","article-title":"Gold complex QB1561 suppresses drug-resistant cancer cells by inhibiting TrxR and mitochondrial respiratory function","volume":"16","author":"Gao","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.redox.2026.104209_bib219","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116218","article-title":"Inhibition of the thioredoxin system for radiosensitization therapy of cancer","volume":"268","author":"Cao","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.redox.2026.104209_bib220","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41420-019-0229-8","article-title":"CD40 induces renal cell carcinoma-specific differential regulation of TRAF proteins, ASK1 activation and JNK\/p38-mediated, ROS-Dependent mitochondrial apoptosis","volume":"5","author":"Ibraheem","year":"2019","journal-title":"Cell Death Discov."},{"issue":"5","key":"10.1016\/j.redox.2026.104209_bib221","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1172\/JCI85339","article-title":"Dual targeting of the thioredoxin and glutathione systems in cancer and HIV","volume":"126","author":"Benhar","year":"2016","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib222","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41572-023-00452-3","article-title":"HIV infection","volume":"9","author":"Bekker","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.redox.2026.104209_bib223","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1742-4690-9-97","article-title":"Cell-type specific requirements for thiol\/disulfide exchange during HIV-1 entry and infection","volume":"9","author":"Stantchev","year":"2012","journal-title":"Retrovirology"},{"key":"10.1016\/j.redox.2026.104209_bib224","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2025.1651148","article-title":"Redox regulation of HIV-1: the thioredoxin pathway, oxidative metabolism, and latency control","volume":"16","author":"Mangold","year":"2025","journal-title":"Front. Physiol."},{"issue":"19","key":"10.1016\/j.redox.2026.104209_bib225","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2313823121","article-title":"Monocyte to macrophage differentiation and changes in cellular redox homeostasis promote cell type-specific HIV latency reactivation","volume":"121","author":"Blanco","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.redox.2026.104209_bib226","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0161-5890(01)00109-2","article-title":"Thioredoxin-mediated redox control of human T cell lymphotropic virus type I (HTLV-I) gene expression","volume":"38","author":"Sasada","year":"2002","journal-title":"Mol. Immunol."},{"issue":"3","key":"10.1016\/j.redox.2026.104209_bib227","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1089\/15230860050192323","article-title":"Genetic and metabolic control of the mitochondrial transmembrane potential and reactive oxygen intermediate production in HIV disease","volume":"2","author":"Perl","year":"2000","journal-title":"Antioxidants Redox Signal."},{"issue":"15","key":"10.1016\/j.redox.2026.104209_bib228","doi-asserted-by":"crossref","first-page":"11380","DOI":"10.1016\/S0021-9258(18)82135-4","article-title":"Oxidoreductive regulation of nuclear factor kappa B. Involvement of a cellular reducing catalyst thioredoxin","volume":"268","author":"Hayashi","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.redox.2026.104209_bib229","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/intimm\/4.7.811","article-title":"Human thioredoxin\/adult T cell leukemia-derived factor activates the enhancer binding protein of human immunodeficiency virus type 1 by thiol redox control mechanism","volume":"4","author":"Okamoto","year":"1992","journal-title":"Int. Immunol."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib230","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0378-4274(02)00083-8","article-title":"Effect of arsenic on transcription factor AP-1 and NF-kappaB DNA binding activity and related gene expression","volume":"133","author":"Hu","year":"2002","journal-title":"Toxicol. Lett."},{"issue":"2","key":"10.1016\/j.redox.2026.104209_bib231","first-page":"461","article-title":"[EBV-related malignancies and thioredoxin]","volume":"55","author":"Noda","year":"1997","journal-title":"Nihon Rinsho"},{"issue":"5","key":"10.1016\/j.redox.2026.104209_bib232","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/art.1780390509","article-title":"Increased expression of human thioredoxin\/adult T cell leukemia-derived factor in sj\u00f6gren's syndrome","volume":"39","author":"Saito","year":"1996","journal-title":"Arthritis Rheum."},{"issue":"44","key":"10.1016\/j.redox.2026.104209_bib233","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.3748\/wjg.v17.i44.4890","article-title":"Serum manganese superoxide dismutase and thioredoxin are potential prognostic markers for hepatitis C virus-related hepatocellular carcinoma","volume":"17","author":"Tamai","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.redox.2026.104209_bib234","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jprot.2014.10.007","article-title":"Effect of CDNB on filarial thioredoxin reductase : a proteomic and biochemical approach","volume":"113","author":"Tiwari","year":"2014","journal-title":"J. Proteonomics"},{"key":"10.1016\/j.redox.2026.104209_bib235","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijbiomac.2019.09.083","article-title":"A review on the druggability of a thiol-based enzymatic antioxidant thioredoxin reductase for treating filariasis and other parasitic infections","volume":"142","author":"Joardar","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"issue":"11","key":"10.1016\/j.redox.2026.104209_bib236","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1089\/ars.2019.7807","article-title":"Anti-allergic and anti-inflammatory effects and molecular mechanisms of thioredoxin on respiratory system diseases","volume":"32","author":"Zhou","year":"2020","journal-title":"Antioxidants Redox Signal."},{"issue":"1\u20132","key":"10.1016\/j.redox.2026.104209_bib237","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1089\/ars.2005.7.60","article-title":"Redox regulation of lung inflammation by thioredoxin","volume":"7","author":"Nakamura","year":"2005","journal-title":"Antioxidants Redox Signal."},{"issue":"8","key":"10.1016\/j.redox.2026.104209_bib238","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3109\/10715762.2011.574290","article-title":"Antioxidant protection: a promising therapeutic intervention in neurodegenerative disease","volume":"45","author":"Ghosh","year":"2011","journal-title":"Free Radic. Res."},{"issue":"10","key":"10.1016\/j.redox.2026.104209_bib239","doi-asserted-by":"crossref","first-page":"7900","DOI":"10.1007\/s12035-018-0917-z","article-title":"Thioredoxin-interacting protein (TXNIP) in cerebrovascular and neurodegenerative diseases: regulation and implication","volume":"55","author":"Nasoohi","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.redox.2026.104209_bib240","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3233\/JAD-131814","article-title":"Alteration of thioredoxin and glutaredoxin in the progression of Alzheimer's disease","volume":"39","author":"Arodin","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.redox.2026.104209_bib241","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177806","article-title":"Thioredoxin-interacting protein: an emerging target for Alzheimer's disease","volume":"1002","author":"Patil","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib242","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13195-022-00979-9","article-title":"Serum Thioredoxin-80 is associated with age, ApoE4, and neuropathological biomarkers in Alzheimer's disease: a potential early sign of AD","volume":"14","author":"Goikolea","year":"2022","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.redox.2026.104209_bib243","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.661505","volume":"13","author":"Samidurai","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.redox.2026.104209_bib244","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.freeradbiomed.2018.06.029","article-title":"Trx-1 ameliorates learning and memory deficits in MPTP-induced Parkinson's disease model in mice","volume":"124","author":"Zhang","year":"2018","journal-title":"Free Radical Biol. Med."},{"issue":"2","key":"10.1016\/j.redox.2026.104209_bib245","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/bbrc.1997.7804","article-title":"Stability of mutant superoxide dismutase-1 associated with familial amyotrophic lateral sclerosis determines the manner of copper release and induction of thioredoxin in erythrocytes","volume":"241","author":"Ogawa","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.redox.2026.104209_bib246","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.redox.2015.04.004","article-title":"Thiol redox homeostasis in neurodegenerative disease","volume":"5","author":"McBean","year":"2015","journal-title":"Redox Biol."},{"issue":"11","key":"10.1016\/j.redox.2026.104209_bib247","article-title":"The role of the thioredoxin System in brain diseases","volume":"11","author":"Bj\u00f8rklund","year":"2022","journal-title":"Antioxidants (Basel, Switzerland)"},{"issue":"7","key":"10.1016\/j.redox.2026.104209_bib248","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1089\/ars.2008.2379","article-title":"Thioredoxin-1 and endothelial cell aging: role in cardiovascular diseases","volume":"11","author":"Altschmied","year":"2009","journal-title":"Antioxidants Redox Signal."},{"issue":"11","key":"10.1016\/j.redox.2026.104209_bib249","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1161\/01.RES.0000102869.39150.23","article-title":"Thioredoxin: a key regulator of cardiovascular homeostasis","volume":"93","author":"Yamawaki","year":"2003","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.redox.2026.104209_bib250","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.atherosclerosis.2005.06.034","article-title":"Oxidized LDL induces a coordinated up-regulation of the glutathione and thioredoxin systems in human macrophages","volume":"185","author":"H\u00e4gg","year":"2005","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib251","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.atherosclerosis.2010.06.002","article-title":"Decreased serum levels of thioredoxin in patients with coronary artery disease plus hyperhomocysteinemia is strongly associated with the disease severity","volume":"212","author":"Wu","year":"2010","journal-title":"Atherosclerosis"},{"issue":"376","key":"10.1016\/j.redox.2026.104209_bib252","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf6094","article-title":"Thioredoxin reverses age-related hypertension by chronically improving vascular redox and restoring eNOS function","volume":"9","author":"Hilgers","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.redox.2026.104209_bib253","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.bbagen.2019.03.007","article-title":"Role and mechanism of homocysteine in affecting hepatic protein-tyrosine phosphatase 1B","volume":"1863","author":"Liu","year":"2019","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"3","key":"10.1016\/j.redox.2026.104209_bib254","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.yjmcc.2011.12.009","article-title":"Homocysteine induces cardiomyocyte dysfunction and apoptosis through p38 MAPK-mediated increase in oxidant stress","volume":"52","author":"Wang","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"9\u201310","key":"10.1016\/j.redox.2026.104209_bib255","article-title":"Thioredoxin-1 is required for the cardioprotecive effect of sildenafil against ischaemia\/reperfusion injury and mitochondrial dysfunction in mice","volume":"53","author":"Zaobornyj","year":"2019","journal-title":"Free Radic. Res."},{"issue":"2","key":"10.1016\/j.redox.2026.104209_bib256","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1089\/ars.2015.6459","article-title":"Thioredoxin-1 attenuates ventricular and mitochondrial postischemic dysfunction in the stunned myocardium of transgenic mice","volume":"25","author":"Perez","year":"2016","journal-title":"Antioxidants Redox Signal."},{"issue":"7","key":"10.1016\/j.redox.2026.104209_bib257","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ejheart.2004.03.003","article-title":"Elevated circulating levels of thioredoxin and stress in chronic heart failure","volume":"6","author":"Jekell","year":"2004","journal-title":"Eur. J. Heart Fail."},{"issue":"6","key":"10.1016\/j.redox.2026.104209_bib258","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1113\/expphysiol.2012.064832","article-title":"Time course of hydrogen peroxide-thioredoxin balance and its influence on the intracellular signalling in myocardial infarction","volume":"97","author":"Schenkel","year":"2012","journal-title":"Exp. Physiol."},{"issue":"6","key":"10.1016\/j.redox.2026.104209_bib259","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1089\/ars.2007.1985","article-title":"Thioredoxin in vascular biology: role in hypertension","volume":"10","author":"Ebrahimian","year":"2008","journal-title":"Antioxidants Redox Signal."},{"issue":"4","key":"10.1016\/j.redox.2026.104209_bib260","first-page":"240","article-title":"Cardiovascular disease: thioredoxin lowers hypertension","volume":"16","author":"Crunkhorn","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.redox.2026.104209_bib261","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102140","article-title":"Insulin signaling alters antioxidant capacity in the diabetic heart","volume":"47","author":"Matsuzaki","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2026.104209_bib262","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103297","article-title":"Disulfide stress and its role in cardiovascular diseases","volume":"75","author":"Qian","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2026.104209_bib263","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.718235","article-title":"The role of thioredoxin\/peroxiredoxin in the \u03b2-Cell defense against oxidative damage","volume":"12","author":"Stancill","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.redox.2026.104209_bib264","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101570","article-title":"Paracrine regulation and improvement of \u03b2-cell function by thioredoxin","volume":"34","author":"Hanschmann","year":"2020","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib265","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s13098-023-01216-5","article-title":"Irisin suppresses pancreatic \u03b2 cell pyroptosis in T2DM by inhibiting the NLRP3-GSDMD pathway and activating the Nrf2-TrX\/TXNIP signaling axis","volume":"15","author":"Li","year":"2023","journal-title":"Diabetol. Metab. Syndr."},{"issue":"8","key":"10.1016\/j.redox.2026.104209_bib266","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2020.129630","article-title":"New insights into serum\/extracellular thioredoxin in regulating hepatic insulin receptor activation","volume":"1864","author":"Bai","year":"2020","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"12","key":"10.1016\/j.redox.2026.104209_bib267","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.3945\/jn.108.089482","article-title":"Redox regulation of protein tyrosine phosphatase 1B by manipulation of dietary selenium affects the triglyceride concentration in rat liver","volume":"138","author":"Mueller","year":"2008","journal-title":"J. Nutr."},{"issue":"9","key":"10.1016\/j.redox.2026.104209_bib268","article-title":"Thioredoxin\/glutaredoxin systems and gut microbiota in NAFLD: interplay, mechanism, and therapeutical potential","volume":"12","author":"Zhu","year":"2023","journal-title":"Antioxidants (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib269","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/jcp.25921","article-title":"All-trans retinoic acid ameliorates hepatic stellate cell activation via suppression of thioredoxin interacting protein expression","volume":"233","author":"Shimizu","year":"2017","journal-title":"J. Cell. Physiol."},{"issue":"9","key":"10.1016\/j.redox.2026.104209_bib270","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1136\/gutjnl-2021-325065","article-title":"Targeting ER protein TXNDC5 in hepatic stellate cell mitigates liver fibrosis by repressing non-canonical TGF\u03b2 signalling","volume":"71","author":"Hung","year":"2021","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.redox.2026.104209_bib271","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1161\/CIRCRESAHA.121.318093","article-title":"Obesity, adipose tissue and vascular dysfunction","volume":"128","author":"Koenen","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.redox.2026.104209_bib272","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.152317","article-title":"Selenoproteins in adipose tissue and obesity","volume":"777","author":"Yang","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.redox.2026.104209_bib273","article-title":"Endothelial dysfunction: redox imbalance, NLRP3 inflammasome, and inflammatory responses in cardiovascular diseases","volume":"14","author":"Penna","year":"2025","journal-title":"Antioxidants (Basel, Switzerland)"},{"issue":"33","key":"10.1016\/j.redox.2026.104209_bib274","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.2174\/138161207782360537","article-title":"Thioredoxin and thioredoxin reductase as redox-sensitive molecular targets for cancer therapy","volume":"13","author":"Pennington","year":"2007","journal-title":"Curr. Pharm. Des."},{"issue":"12","key":"10.1016\/j.redox.2026.104209_bib275","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/j.bbadis.2013.07.010","article-title":"Glutathione peroxidase contributes with heme oxygenase-1 to redox balance in mouse brain during the course of cerebral malaria","volume":"1832","author":"Linares","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.redox.2026.104209_bib276","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4698167","article-title":"TXNRD1 is an unfavorable prognostic factor for patients with hepatocellular carcinoma","volume":"2017","author":"Fu","year":"2017","journal-title":"Biomed Res. Int."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib277","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1038\/s41598-021-85688-3","article-title":"Clinical application of thioredoxin reductase as a novel biomarker in liver cancer","volume":"11","author":"Wu","year":"2021","journal-title":"Sci. Rep."},{"issue":"19","key":"10.1016\/j.redox.2026.104209_bib278","doi-asserted-by":"crossref","first-page":"17792","DOI":"10.18632\/oncotarget.3785","article-title":"Thioredoxin reductase: a novel, independent prognostic marker in patients with hepatocellular carcinoma","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.redox.2026.104209_bib279","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1007\/s10147-023-02350-w","article-title":"Thioredoxin reductase as a novel biomarker for the diagnosis and efficacy prediction of gastrointestinal malignancy: a large-scale, retrospective study","volume":"28","author":"Hu","year":"2023","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.redox.2026.104209_bib280","doi-asserted-by":"crossref","DOI":"10.1177\/15330338231184995","article-title":"Plasma thioredoxin reductase as a potential biomarker for gynecologic cancer","volume":"22","author":"Zhu","year":"2023","journal-title":"Technol. Cancer Res. Treat."},{"issue":"6","key":"10.1016\/j.redox.2026.104209_bib281","doi-asserted-by":"crossref","DOI":"10.1016\/j.clbc.2024.03.008","article-title":"Plasma thioredoxin reductase as a potential diagnostic biomarker for breast cancer","volume":"24","author":"Hu","year":"2024","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.redox.2026.104209_bib282","doi-asserted-by":"crossref","first-page":"e1299","DOI":"10.1016\/j.wneu.2022.09.024","article-title":"Thioredoxin system and miR-21, miR-23a\/b and let-7a as potential biomarkers for brain tumor progression: preliminary case data","volume":"167","author":"K\u0131l\u0131\u00e7","year":"2022","journal-title":"World Neurosurg."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib283","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1038\/s41598-018-38153-7","article-title":"Thioredoxin reductase as a novel and efficient plasma biomarker for the detection of non-small cell lung cancer: a large-scale, multicenter study","volume":"9","author":"Ye","year":"2019","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.redox.2026.104209_bib284","doi-asserted-by":"crossref","first-page":"757","DOI":"10.21037\/tlcr-22-300","article-title":"Association between changes in thioredoxin reductase and other peripheral blood biomarkers with response to PD-1 inhibitor-based combination immunotherapy in non-small cell lung cancer: a retrospective study","volume":"11","author":"Wen","year":"2022","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.redox.2026.104209_bib285","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3389\/fmicb.2018.00336","article-title":"Repurposing auranofin, ebselen, and PX-12 as antimicrobial agents targeting the thioredoxin system","volume":"9","author":"May","year":"2018","journal-title":"Front. Microbiol."},{"issue":"30","key":"10.1016\/j.redox.2026.104209_bib286","doi-asserted-by":"crossref","first-page":"12288","DOI":"10.1073\/pnas.0701549104","article-title":"Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide","volume":"104","author":"Lu","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Pt 6","key":"10.1016\/j.redox.2026.104209_bib287","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1042\/BST0331375","article-title":"Thiol redox control via thioredoxin and glutaredoxin systems","volume":"33","author":"Holmgren","year":"2005","journal-title":"Biochem. Soc. Trans."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib288","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/prot.340110103","article-title":"Structural and functional relations among thioredoxins of different species","volume":"11","author":"Eklund","year":"1991","journal-title":"Proteins"},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib289","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3892\/ijo.2013.2152","article-title":"PX-12 inhibits the growth of A549 lung cancer cells via G2\/M phase arrest and ROS-Dependent apoptosis","volume":"44","author":"You","year":"2013","journal-title":"Int. J. Oncol."},{"issue":"14","key":"10.1016\/j.redox.2026.104209_bib290","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.7150\/thno.85460","article-title":"Nuclear translocation of thioredoxin-1 promotes colorectal cancer development via modulation of the IL-6\/STAT3 signaling axis through interaction with STAT3","volume":"13","author":"Wu","year":"2023","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.redox.2026.104209_bib291","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/ddr.22045","article-title":"PX-12 synergistically enhances the therapeutic efficacy of vorinostat under hypoxic tumor microenvironment in oral squamous cell carcinoma in vitro","volume":"84","author":"Akhlaq","year":"2023","journal-title":"Drug Dev. Res."},{"issue":"3","key":"10.1016\/j.redox.2026.104209_bib292","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00280-010-1343-8","article-title":"A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination","volume":"67","author":"Ramanathan","year":"2010","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"18","key":"10.1016\/j.redox.2026.104209_bib293","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1007\/s40265-019-01229-3","article-title":"Dimethyl fumarate: a review in relapsing-remitting MS","volume":"79","author":"Blair","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.redox.2026.104209_bib294","doi-asserted-by":"crossref","DOI":"10.1038\/srep43168","article-title":"Targeting Thioredoxin-1 by dimethyl fumarate induces ripoptosome-mediated cell death","volume":"7","author":"Schroeder","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2026.104209_bib295","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fonc.2020.00022","article-title":"Fingolimod augments monomethylfumarate killing of GBM cells","volume":"10","author":"Dent","year":"2020","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.redox.2026.104209_bib296","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1182\/blood.2022018669","article-title":"Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study","volume":"142","author":"Nicolay","year":"2023","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib297","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/pro.533","article-title":"Structure of Mycobacterium tuberculosis thioredoxin in complex with quinol inhibitor PMX464","volume":"20","author":"Hall","year":"2011","journal-title":"Protein Sci."},{"issue":"8","key":"10.1016\/j.redox.2026.104209_bib298","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/sj.bjp.0707342","article-title":"A cellular and molecular investigation of the action of PMX464, a putative thioredoxin inhibitor, in normal and colorectal cancer cell lines","volume":"151","author":"Mukherjee","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.redox.2026.104209_bib299","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/bs.acr.2018.02.006","article-title":"Advances and challenges of HDAC inhibitors in cancer therapeutics","volume":"138","author":"McClure","year":"2018","journal-title":"Adv. Cancer Res."},{"issue":"9","key":"10.1016\/j.redox.2026.104209_bib300","article-title":"Sodium butyrate-loaded microspheres with enhanced bioavailability for targeted treatment of intestinal barrier injury","volume":"14","author":"Lv","year":"2024","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.redox.2026.104209_bib301","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2025.128203","article-title":"Clostridium butyricum-induced balance in colonic retinol metabolism and short-chain fatty acid levels inhibit IgA-related mucosal immunity and relieve colitis developments","volume":"298","author":"Xu","year":"2025","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.redox.2026.104209_bib302","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.2147\/OTT.S235575","article-title":"Sodium butyrate selectively kills cancer cells and inhibits migration in colorectal cancer by targeting Thioredoxin-1","volume":"13","author":"Wang","year":"2020","journal-title":"OncoTargets Ther."},{"issue":"2","key":"10.1016\/j.redox.2026.104209_bib303","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/cam4.977","article-title":"TXNIP mediates the differential responses of A549 cells to sodium butyrate and sodium 4-phenylbutyrate treatment","volume":"6","author":"Jin","year":"2016","journal-title":"Cancer Med."},{"issue":"10","key":"10.1016\/j.redox.2026.104209_bib304","doi-asserted-by":"crossref","first-page":"910","DOI":"10.2174\/138955711796575416","article-title":"Recent progress in the development of natural ent-kaurane diterpenoids with anti-tumor activity","volume":"11","author":"Wang","year":"2011","journal-title":"Mini Rev. Med. Chem."},{"issue":"4","key":"10.1016\/j.redox.2026.104209_bib305","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1158\/0008-5472.CAN-16-0987","article-title":"The natural diterpenoid isoforretin A inhibits Thioredoxin-1 and triggers potent ROS-mediated antitumor effects","volume":"77","author":"Sun","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.redox.2026.104209_bib306","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101975","article-title":"Glutaredoxin: discovery, redox defense and much more","volume":"43","author":"Ogata","year":"2021","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib307","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-31048-7","article-title":"Inhibition of the glutaredoxin and thioredoxin systems and ribonucleotide reductase by mutant p53-targeting compound APR-246","volume":"8","author":"Haffo","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2026.104209_bib308","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fonc.2016.00021","article-title":"Targeting of mutant p53 and the cellular redox balance by APR-246 as a strategy for efficient cancer therapy","volume":"6","author":"Bykov","year":"2016","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib309","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13062-025-00594-2","article-title":"Bi-targeting of thioredoxin 1 and telomerase by thiotert promotes cell death of myelodysplastic syndromes and lymphoma","volume":"20","author":"Jing","year":"2025","journal-title":"Biol. Direct"},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib310","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s11658-024-00570-0","article-title":"Role of reactive oxygen species in myelodysplastic syndromes","volume":"29","author":"Jing","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.redox.2026.104209_bib311","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103367","article-title":"Iron overload-induced oxidative stress in myelodysplastic syndromes and its cellular sequelae","volume":"163","author":"Kim","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"5","key":"10.1016\/j.redox.2026.104209_bib312","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26052084","article-title":"Inhibition of thioredoxin-reductase by auranofin as a pro-oxidant anticancer strategy for glioblastoma: in vitro and in vivo studies","volume":"26","author":"Chmelyuk","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.redox.2026.104209_bib313","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/japtr.JAPTR_289_18","article-title":"Formulation, characterization, and in vitro testing of azelaic acid ethosome-based cream against Propionibacterium acnes for the treatment of acne","volume":"10","author":"Apriani","year":"2019","journal-title":"J. Adv. Pharm. Technol. Res."},{"issue":"3","key":"10.1016\/j.redox.2026.104209_bib314","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0304-3835(87)90023-1","article-title":"Azelaic acid as a competitive inhibitor of thioredoxin reductase in human melanoma cells","volume":"36","author":"Schallreuter","year":"1987","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.redox.2026.104209_bib315","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1080\/09546634.2020.1800579","article-title":"The versatility of azelaic acid in dermatology","volume":"33","author":"Searle","year":"2020","journal-title":"J. Dermatol. Treat."},{"issue":"4","key":"10.1016\/j.redox.2026.104209_bib316","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-2133.1987.tb05886.x","article-title":"Azelaic acid in lentigo maligna","volume":"116","year":"1987","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.redox.2026.104209_bib317","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1017\/neu.2024.55","article-title":"The effect of azelaic acid on AlCl3-induced neurocognitive impairments and molecular changes in the hippocampus of rats","volume":"37","author":"Vasegh","year":"2024","journal-title":"Acta Neuropsychiatr."},{"issue":"4","key":"10.1016\/j.redox.2026.104209_bib318","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2174\/1381612825666190312105755","article-title":"Fatty acids and antioxidants in multiple sclerosis: therapeutic role of GEMSP","volume":"25","author":"Ahumada-Pascual","year":"2019","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.redox.2026.104209_bib319","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0165-5728(89)90043-X","article-title":"Identification and characterization of anti-conjugated azelaic acid antibodies in multiple sclerosis","volume":"22","author":"Daverat","year":"1989","journal-title":"J. Neuroimmunol."},{"issue":"9","key":"10.1016\/j.redox.2026.104209_bib320","first-page":"964","article-title":"Azelaic acid: evidence-based update on mechanism of action and clinical application","volume":"14","author":"Schulte","year":"2015","journal-title":"J. Drugs Dermatol. JDD"},{"issue":"5","key":"10.1016\/j.redox.2026.104209_bib321","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/bjp.2008.161","article-title":"Arsenic trioxide and auranofin inhibit selenoprotein synthesis: implications for chemotherapy for acute promyelocytic leukaemia","volume":"154","author":"Talbot","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.redox.2026.104209_bib322","article-title":"Pharmacological rescue of mutant p53 triggers spontaneous tumor regression via immune responses","volume":"6","author":"Li","year":"2025","journal-title":"Cell Rep. Med."},{"issue":"4","key":"10.1016\/j.redox.2026.104209_bib323","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1007\/s11033-021-06377-y","article-title":"Effect of lycopene on As2O3 induced oxidative stress in SH-SY5Y cells","volume":"48","author":"Oguz","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.redox.2026.104209_bib324","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.freeradbiomed.2019.11.013","article-title":"The novel thioredoxin reductase inhibitor A-Z2 triggers intrinsic apoptosis and shows efficacy in the treatment of acute myeloid leukemia","volume":"146","author":"Zhang","year":"2019","journal-title":"Free Radical Biol. Med."},{"issue":"13","key":"10.1016\/j.redox.2026.104209_bib325","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1039\/D1CS00933H","article-title":"Recent development of gold(I) and gold(III) complexes as therapeutic agents for cancer diseases","volume":"51","author":"Lu","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib326","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12672-021-00439-0","article-title":"The gold complex auranofin: new perspectives for cancer therapy","volume":"12","author":"Abdalbari","year":"2021","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.redox.2026.104209_bib327","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ijpharm.2018.11.057","article-title":"Smart mitochondrial-targeted cancer therapy: subcellular distribution, selective TrxR2 inhibition accompany with declined antioxidant capacity","volume":"555","author":"Du","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib328","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.yexcr.2016.04.014","article-title":"TrxR2 deficiencies promote chondrogenic differentiation and induce apoptosis of chondrocytes through mitochondrial reactive oxygen species","volume":"344","author":"Yan","year":"2016","journal-title":"Exp. Cell Res."},{"issue":"7","key":"10.1016\/j.redox.2026.104209_bib329","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11070931","article-title":"Synergy between auranofin and celecoxib against Colon cancer in vitro and in vivo through a novel redox-mediated mechanism","volume":"11","author":"Han","year":"2019","journal-title":"Cancers"},{"issue":"22","key":"10.1016\/j.redox.2026.104209_bib330","doi-asserted-by":"crossref","first-page":"35728","DOI":"10.18632\/oncotarget.16113","article-title":"Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.redox.2026.104209_bib331","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/CAD.0000000000001540","article-title":"Auranofin inhibits the occurrence of colorectal cancer by promoting mTOR-dependent autophagy and inhibiting epithelial-mesenchymal transformation","volume":"35","author":"Zhang","year":"2023","journal-title":"Anti Cancer Drugs"},{"issue":"15","key":"10.1016\/j.redox.2026.104209_bib332","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1158\/1078-0432.CCR-18-2751","article-title":"Auranofin protects intestine against radiation injury by modulating p53\/p21 pathway and radiosensitizes human Colon tumor","volume":"25","author":"Nag","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.redox.2026.104209_bib333","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41419-017-0159-4","article-title":"Elimination of stem-like cancer cell side-population by auranofin through modulation of ROS and glycolysis","volume":"9","author":"Hou","year":"2018","journal-title":"Cell Death Dis."},{"issue":"Pt B","key":"10.1016\/j.redox.2026.104209_bib334","article-title":"Auranofin: past to present, and repurposing","volume":"101","author":"Yamashita","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.redox.2026.104209_bib335","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/15287394.2020.1835762","article-title":"Combined treatment with auranofin and trametinib induces synergistic apoptosis in breast cancer cells","volume":"84","author":"Joo","year":"2020","journal-title":"J. Toxicol. Environ. Health"},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib336","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41419-023-05586-6","article-title":"Dual inhibition of thioredoxin reductase and proteasome is required for auranofin-induced paraptosis in breast cancer cells","volume":"14","author":"Seo","year":"2023","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.redox.2026.104209_bib337","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.3892\/or.2020.7818","article-title":"Auranofin inhibits the proliferation of lung cancer cells via necrosis and caspase-dependent apoptosis","volume":"44","author":"Cui","year":"2020","journal-title":"Oncol. Rep."},{"issue":"6","key":"10.1016\/j.redox.2026.104209_bib338","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1007\/s10637-019-00750-2","article-title":"A high-throughput drug screen identifies auranofin as a potential sensitizer of cisplatin in small cell lung cancer","volume":"37","author":"Liu","year":"2019","journal-title":"Invest. N. Drugs"},{"issue":"11","key":"10.1016\/j.redox.2026.104209_bib339","article-title":"Conception and evaluation of fluorescent phosphine-gold complexes: from synthesis to in vivo investigations","volume":"17","author":"Rousselle","year":"2022","journal-title":"ChemMedChem"},{"issue":"16","key":"10.1016\/j.redox.2026.104209_bib340","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24162930","article-title":"Curcumin: biological, pharmaceutical, nutraceutical, and analytical aspects","volume":"24","author":"Kotha","year":"2019","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"5","key":"10.1016\/j.redox.2026.104209_bib341","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1021\/acs.jmedchem.5b01203","article-title":"Discovery of new monocarbonyl Ligustrazine-Curcumin hybrids for intervention of drug-sensitive and drug-resistant lung cancer","volume":"59","author":"Ai","year":"2016","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.redox.2026.104209_bib342","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/carcin\/bgh163","article-title":"Curcumin impairs tumor suppressor p53 function in colon cancer cells","volume":"25","author":"Moos","year":"2004","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib343","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2022.2162807","article-title":"Curcumin analog WZ26 induces ROS and cell death via inhibition of STAT3 in cholangiocarcinoma","volume":"24","author":"Chen","year":"2023","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.redox.2026.104209_bib344","doi-asserted-by":"crossref","DOI":"10.1016\/j.freeradbiomed.2019.06.005","article-title":"Curcuminoid WZ26, a TrxR1 inhibitor, effectively inhibits colon cancer cell growth and enhances cisplatin-induced cell death through the induction of ROS","volume":"141","author":"Zhang","year":"2019","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.redox.2026.104209_bib345","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.canlet.2019.02.034","article-title":"Piperlongumine increases sensitivity of colorectal cancer cells to radiation: involvement of ROS production via dual inhibition of glutathione and thioredoxin systems","volume":"450","author":"Wang","year":"2019","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.redox.2026.104209_bib346","article-title":"Piperlongumine inhibits thioredoxin reductase 1 by targeting selenocysteine residues and sensitizes cancer cells to erastin","volume":"11","author":"Yang","year":"2022","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"10.1016\/j.redox.2026.104209_bib347","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177478","article-title":"Piperlongumine induces ROS accumulation to reverse resistance of 5-FU in human colorectal cancer via targeting TrxR","volume":"997","author":"Zhou","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.redox.2026.104209_bib348","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1093\/jpp\/rgae148","article-title":"Piperlongumine inhibits glioblastoma proliferation by inducing ferroptosis","volume":"77","author":"Qiu","year":"2025","journal-title":"J. Pharm. Pharmacol."},{"issue":"7","key":"10.1016\/j.redox.2026.104209_bib349","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27072086","article-title":"Deoxyelephantopin and its isomer isodeoxyelephantopin: anti-cancer natural products with multiple modes of action","volume":"27","author":"Mehmood","year":"2022","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/j.redox.2026.104209_bib350","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.580517","article-title":"Isodeoxyelephantopin inactivates thioredoxin reductase 1 and activates ROS-mediated JNK signaling pathway to exacerbate cisplatin effectiveness in human Colon cancer cells","volume":"8","author":"Hong","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"9","key":"10.1016\/j.redox.2026.104209_bib351","doi-asserted-by":"crossref","DOI":"10.1002\/fsn3.70737","article-title":"Isodeoxyelephantopin promotes cell death in triple-negative breast cancer by blocking STAT3 phosphorylation and enhancing the effectiveness of paclitaxel","volume":"13","author":"Lin","year":"2025","journal-title":"Food Sci. Nutr."},{"issue":"5","key":"10.1016\/j.redox.2026.104209_bib352","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.freeradbiomed.2011.11.034","article-title":"Ethaselen: a potent mammalian thioredoxin reductase 1 inhibitor and novel organoselenium anticancer agent","volume":"52","author":"Wang","year":"2011","journal-title":"Free Radical Biol. Med."},{"issue":"1","key":"10.1016\/j.redox.2026.104209_bib353","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13046-022-02268-7","article-title":"Retraction note: ethaselen synergizes with oxaliplatin in tumor growth inhibition by inducing ROS production and inhibiting TrxR1 activity in gastric cancer","volume":"41","author":"Zhang","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.redox.2026.104209_bib354","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103827","article-title":"Novel thioredoxin reductase 1 inhibitor BS1801 relieves treatment resistance and triggers endoplasmic reticulum stress by elevating reactive oxygen species in glioma","volume":"86","author":"Chang","year":"2025","journal-title":"Redox Biol."},{"issue":"4","key":"10.1016\/j.redox.2026.104209_bib355","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.addr.2009.01.003","article-title":"Thioredoxin 1 delivery as new therapeutics","volume":"61","author":"Nakamura","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"11","key":"10.1016\/j.redox.2026.104209_bib356","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115600","article-title":"Recombinant long-acting thioredoxin ameliorates AKI to CKD transition via modulating renal oxidative stress and inflammation","volume":"22","author":"Nishida","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.redox.2026.104209_bib357","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1016\/j.molcel.2021.08.018","article-title":"Redox metabolism: ROS as specific molecular regulators of cell signaling and function","volume":"81","author":"Lennicke","year":"2021","journal-title":"Mol. Cell"},{"issue":"12","key":"10.1016\/j.redox.2026.104209_bib358","doi-asserted-by":"crossref","first-page":"6146","DOI":"10.1073\/pnas.93.12.6146","article-title":"Selenocysteine, identified as the penultimate C-terminal residue in human T-cell thioredoxin reductase, corresponds to TGA in the human placental gene","volume":"93","author":"Gladyshev","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2026.104209_bib359","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105854","article-title":"Thioredoxin reductase as a pharmacological target","volume":"174","author":"Bj\u00f8rklund","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"8","key":"10.1016\/j.redox.2026.104209_bib360","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/13543776.2021.1899160","article-title":"Thioredoxin reductase inhibitors: updated patent review (2017-present)","volume":"31","author":"Chupakhin","year":"2021","journal-title":"Expert Opin. Ther. Pat."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231726002077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231726002077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:14:49Z","timestamp":1783073689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231726002077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":360,"alternative-id":["S2213231726002077"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2026.104209","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Crosstalk of thioredoxin system and programmed cell death: from pathophysiology to novel therapy","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2026.104209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104209"}}